Competitive Benchmarking

Leaders:

• SIG is the prominent leader in the caps and closures market, leveraging unique strengths that contribute to their market dominance. SIG caps and closures are tethered closures that stay on the packaging after the product is ingested. The company exercise sustainability in its designed which facilitate recycling because the cap remains attached to the pack, preventing littering and increasing the likelihood that the product will be recovered and recycled together after use. Investing in regional expansion has improved SIG’s market image, for instance, the company introduced tethered lids for its beverage cartons in Europe in the second half of 2021, well ahead of the July 2024 date stipulated by EU rules. The revised caps prioritize ease and will be compatible with existing filling machines and closure applicators, giving customers confidence in investing in a long-term partnership with SIG to provide food and beverages to consumers in a safe, sustainable, and cost-effective manner.
• Berry Global, Inc. (Berry Global Gr) is another prominent leader in the caps and closures market. Berry Global is a market leader in beverage system capsules and 50ml PET bottle manufacture. They also provide a variety of closures, hot and cold solutions, and packaging overwrap film. The company has targeted drug delivery, drug manufacturing, first aid, medical components, and more and has emphasized on new launches. For instance, in September 2024, Berry Global introduced a tamper-evident pouring closure for edible oils, dressings, and sauces that blends customer convenience and functionality with sustainability features that boost recyclability.

KSI VP Matrix

 

Knowledge Sourcing Intelligence Vendor Positioning Matrix

Particulars	Ability To Improve Market Position	Resilience
Leader	Medium	High
Follower	High	High
Challenger	Medium	Medium
Niche	Low	Low

Follower:

• Saint-Gobain Life Sciences (Saint-Gobain S.A.) is considered a follower as the company is aiming to expand its portfolio. The company manufactures medical grade caps, silicone stoppers, and liners which are applied in variety of industries, including cell culture, pharmaceuticals, medical devices, environmental, and chemical packing. Saint-Gobain develops bespoke single-use solutions for the biopharmaceutical industrial business. This includes bioprocess containers, connectors, closures, and tubing, as well as goods from well-known brands such as TYGON®, Sani-Tech®, C-Flex®, Pure-Fit®, and many more.
• BERICAP is a German company that makes closures for beverage containers, food, and other industries. BERICAP provides a wide variety of closures, including one- and two-piece closures, hinge closures, tamper-evident screw caps, and pull-up spouts. They also provide solutions for food oils, sauces, and dressings. BERICAP is credited with creating the DoubleSeal system, which consists of an inner and outer seal for enhanced sealing performance. They also have specialist R&D labs and a mold shop to create unique closures.

Challenger:

• Closure Systems International Inc. (CSI) is a pioneer in the design and manufacture of innovative closures for a variety of consumer and industrial applications. In addition to high-quality closures and capping equipment, CSI offers exceptional customer and technical support for high-speed application systems. Carbonated soft drinks, bottled water, juices, isotonics, teas, adult beverages, dairy, meals, pharmaceuticals, and automotive fluids are among the most commonly supplied items. CSI’s cutting-edge closure solutions assist companies in maximizing earnings by boosting brand marketability and optimizing total operating costs.
• Silgan Closures has carved its name in the food and beverage closure production sector, with more than $6 billion in sales in 2023 and 107 production locations spread across four continents, the company has developed into a major worldwide provider of environmentally friendly rigid packaging solutions for consumer goods items. Their main product lines include dispensing and specialty closures, metal containers, and custom containers. They take great pride in the fact that their products protect some of the world’s most well-known branded and private label consumer products, and their food packaging products enable their customers to feed and care for the world in a cost-effective and sustainable manner.

Niche:

• Alpha India Pvt. Ltd., Syscom Packaging Holding, Chemco Group, and Pranil Polymers. are regarded as niche players in the caps and closures industry because of their small product offerings, limited brand presence, and strategic market positioning. The companies, meanwhile, are focusing on strengthening their internet footprint and offering affordable caps and closures.

Premium alcohol has quality ingredients and time-honored distillation techniques. Premium spirits have the sophistication for taste and smell. The emergence of high-end, large-format retail stores in growing economies is boosting the demand for premium alcohol. These stores are also drawing people of all demographics. According to the ICRA (Investment Information and Credit Rating Agency), India witnessed a 9% increase in revenue in Q1FY25. The policy changes by several countries expanded the brand choice offering both domestic and international brands to the customers. The easy payment system by digitalization has played a significant role in the increase of sales in the sector.

Further, the increasing consumption of alcohol globally has also influenced many companies to provide premium and different varieties of alcohol. For instance, according to data from the OECD, in 2021 France had a consumption of 10.6 Litres/per capita (aged 15 and over) which surged to 10.8 in 2022, similarly, Spain has per 10.4 Litres/capita (aged 15 and over) in 2021 which surged to 11.8 in 2022.

Alcohol Consumption, Spain and France, Litres Per Capita (Aged 15 and Over), 2021 and 2022

Source: OECD

Top companies in the premium alcohol market

• Pernod Ricard SA
• Diageo Plc
• Bacardi Limited
• The Brown-Forman Corporation
• Hermes Distillery

Let’s discuss each in detail.

Pernod Ricard SA

Pernod Ricard is a significant player in premium international wines and spirits. The company has several iconic brands. Such as Absolut Elyx, Perrier-Jouët, Havana Club, and Chivas among others

• Maison Perrier-Jouët is one of France’s most distinctive champagne houses. It is renowned for its floral champagnes produced only in small volumes. It has been operating since 1811. The product offered by the company like Perrier-Jouët Blanc de Blancs is champagne to serve as an aperitif, and it has premium packaging. Perrier-Jouët champagnes are sold in select prestigious outlets all over the world. The optimal aging period of the product depends on the vintage and storage conditions.
• Further, Absolut Elyx is based in Sweden. The brand is owned by Pernod Ricard SA. It manufactures handcrafted vodka, and all of its ingredients are sourced from Sweden only. The vodka produced is distilled in a vintage copper still from 1921 and operated entirely by hand by skilled masters. This unique process creates a vodka with unparalleled purity and flavor and an exceptional mouthfeel.
• Besides, the Havana Club is known for its signature rums. The Maestro del Ron Cubano selects rum bases for their intrinsic qualities to create the desired final product. By blending different rums, the Maestro enhances rum’s character, with portions returning to the barrel, this has been a continuous aging tradition. Additionally, the expertise of Maestros del Ron Cubano has been recognized by UNESCO as a World Intangible Heritage, continuing the legacy of Cuban rum.

Diageo Plc

Diageo is a prominent company in the Total Beverage Alcohol (TBA) and one of the world’s largest brand builders. They own over 200 brands and sales in nearly 180 countries. Their portfolio brings some of the most iconic brands from around the globe. According to the company’s annual report,  the company sold about 4% of its luxury, 5% of the ultra-premium, 16% of the super-premium, and 37% of premium products out of its total portfolio.

According to the company report, the spirits’ long-term value growth is also driven by premiumization as consumers want to drink better. In the last 10 years, premium and above spirits grew from 26% of category value to almost 35%. The super-premium plus price tier has grown in value more than two times faster than other price tiers in the category.

Bacardi Limited

Bacardi Group is the largest privately held spirit company in the world. They have a world-class portfolio of over 200 brands and labels, including BACARDÍ rum, PATRÓN tequila, GREY GOOSE vodka, DEWAR’S Blended Scotch whisky, and BOMBAY SAPPHIRE gin, among others.

The company is expanding into premium single malt and blended scotch whisky. They are investing in the future of the category with the completion of several improvement projects at its production sites across Scotland. In October 2024 the company added three new state-of-the-art aging warehouses at its 200-acre blending and maturation center, Poniel in southeast Glasgow. Meanwhile, at Aultmore Distillery in Speyside, an expansion project was completed to improve efficiency and safety and install new technology to help reduce energy and water consumption on site. The new boiler has also been installed to have the capacity to switch to hydrogen fuel in the future. Their investment in Aultmore and Macduff distilleries and Poniel blending and maturation center was an important step in the premium and ultra-premium whiskies portfolio.

The Brown-Forman Corporation

The Brown-forman Corporation was founded by George Garvin Brown, more than 150 years ago. With employees numbering more than 5,700. From a single brand of Old Forester, in one market, the United States, their portfolio has grown to more than 40 brands sold in more than 170 countries. The company is witnessing staggering growth in its brand revenue and volume.

The company’s Woodford Reserve has grown in double digital and become the number-one super-premium American whiskey brand in the world by volume and value, based on IWSR (International Wine and Spirits Record) 2023. Further, Double Oaked Expression, which was launched in 2012, had grown to be the third-largest ultra-premium American whiskey by volume in the world.

Following this the company acquired the Gin Mare brand and the Diplomático brand and related assets in fiscal 2023. The deal was done at a purchase price of $1.2 billion. In fiscal 2023, these brands positively contributed to net sales growth. The company has well-positioned itself to meet consumer trends and preferences for premium, super-premium, and ultra-premium brands.

Hermes Distillery

Hermes Distillery was founded in 2018 by Amit Kore, an Indian premium brand. It offers several labels, ranging from aspirational to super-premium. Their Rock Dove, a premium whiskey offers exquisite flavors that are both sophisticated for the new generation. It is endorsed by discerning professionals for color, aroma, and taste.

It meets the highest standards and remains exclusive. Further, their offering Murano, is made from molasses and aged in Oak Barrels with added sugar cane. This is offered in 180 ml, 375 ml, and 750 ml packaging. Besides, their Indian Honey is an ultra-premium spirit and is a concoction of anise with aroma. From a copper cauldron, this liquor is passed through a basket of anise seeds and secret ingredients for a distinctive flavor.

Conclusion

With the growing affluence of the middle class, online distribution channels, growing awareness, growth of the millennium population, and higher appreciation for over the third place (OTTP) at home has increased the demand for premiumization. This boosted the brands to elevate their super-premium brands and capture global growth across the category. The global trend is also witnessing the switch to spirits from beer and wine. The premium spirits growth is supported by the favorable population demographics class in key markets globally. The global companies are focusing more on the growing market of Asia Pacific, Middle East, and Africa to expand their offerings.

Competitive Benchmarking

Leaders:

• Johnson & Johnson, Procter & Gamble (P&G), and Nestlé are prominent leaders in the baby care products market, each leveraging unique strengths that contribute to their market dominance. Johnson & Johnson has a long history in the healthcare sector, which it extends into its baby care division. The company provides a complete range of baby products, including shampoos, lotions, and wipes, all known for their gentle formulations. Their commitment to safety and quality resonates with parents, establishing trust and brand loyalty. Among its developments recently, the company has heightened its emphasis on natural and sustainable ingredients in formulations and products to meet the customers’ demands for safe, environmentally friendly products. Through this responsiveness to the current market, Johnson & Johnson has been able to preserve market share.
• Procter & Gamble is also among the most prominent players that majorly boasts of the global diaper market through Pampers. The success of P&G can be attributed to its robust research and development capabilities, which allow for continuous innovation in product design and functionality. Recent initiatives include expanding their product lines to include eco-friendly options and enhancing their marketing strategies to target millennial parents who prioritize sustainability. For instance, in 2021, P&G launched its first BabyCare Innovation Lab at Singapore Innovation Center which will be essential in designing and developing products that serve babies in APAC.
• Nestlé’s presence is mostly through its Gerber brand, which is quite a name in baby foods. Gerber has catered to the growing desire of consumers for organic and non-GMO products by diversifying nutritious products that meet the concerned parent’s expectations. The company’s strategic play on product safety and nutritional value has secured the trust of consumers. Moreover, Nestlé’s extensive global distribution network allows it to reach diverse markets effectively, further enhancing its competitive edge. Key developments in the market are expected to place Nestle in a strong position, for instance, in November 2023, Nestle unveiled its latest innovation in early life nutrition with the launch of a science-based growing-up milk solution containing Human Milk Oligosaccharides (HMOs) in mainland China.

KSI VP Matrix

Knowledge Sourcing Intelligence Vendor Positioning Matrix

Particulars	Ability To Improve Market Position	Resilience
Leader	Medium	High
Follower	High	High
Challenger	Medium	Medium
Niche	Low	Low

Follower:

• Unilever is considered a follower in the baby care products market due to its relatively smaller market share compared to industry leaders like Procter & Gamble and Nestlé. While Unilever offers products under brands like Baby Dove, it lacks the extensive product range and brand recognition that its competitors possess. Recent developments indicate that Unilever is attempting to catch up by focusing on sustainability and digital marketing strategies. Hence, the company has been actively expanding its baby care portfolio through the introduction of new products under its Dove brand. In 2024, the company launched a range of baby care items, including lotions and cleansers, designed to compete directly with established brands like Johnson & Johnson.
• Abbott has a strong presence in infant formula through its Similac brand, it lacks a comprehensive range of baby care items, such as diapers and skincare products, which are critical in this segment. Recent developments indicate that Abbott is focusing on its core strengths in nutrition rather than expanding aggressively into broader baby care categories. For instance, in August 2024, Abbott expanded its Pure Bliss by Similac line of organic, and European-made infant formulas that give parents a variety of products to meet specific formula preferences.

Challenger:

• Kimberly-Clark Corporation is positioned as a challenger in the baby care products market, primarily through its strong Huggies brand, which is well-regarded for diapers and baby wipes. Kimberly-Clark faces intense competition from industry leaders like Procter & Gamble and Johnson & Johnson, which have more extensive product lines and greater brand recognition. Recently, Kimberly-Clark has been focusing on innovation and sustainability to enhance its competitive edge, due to which it has been investing in eco-friendly materials for its products and expanding its online presence to cater to the growing demand for direct-to-consumer sales.
• Pigeon Corporation is a notable challenger in the baby care market, primarily due to its strong focus on high-quality feeding products and baby skincare. The company’s innovative selling and marketing tactics has enabled it to significant recovery in sales, particularly in Singapore and Lansinoh. Moreover, it strategic plan emphasizes entering new markets like North America and Africa while enhancing existing product lines to capture a larger share of the growing baby care segment.
• Dabur International Limited positions itself as a challenger through its Ayurvedic approach to baby care products. With a strong emphasis on natural ingredients, Dabur has successfully carved out a niche in the market by offering products that align with traditional health practices. Recent developments include expanding their product offerings to cater to the rising demand for organic and herbal baby care solutions. The company’s marketing strategies highlight the benefits of using Ayurvedic formulations, appealing to parents seeking safe and effective options for their infants. This focus on health and wellness positions Dabur favorably against larger competitors.

Niche:

• Cotton Babies, HCP Wellness, Chemco Products, Orchid Lifesciences, Jinjiang Rongxin Lady & Baby’s Products Co., Ltd., and Nunu Baby Care Products Ltd. are recognized as niche players in the baby care products market due to their low products, limited brand presence, and strategic market positioning. The companies, however, are emphasizing on improving their digital footprint and offer affordable baby care products.

Introduction

Pharmacovigilance is the science that deals with detecting, assessing, understanding, and preventing adverse effects related to medicines or vaccines. Although all medicines and vaccines undergo rigorous testing procedures to ensure their safety and efficacy before being authorized for use, these tests are conducted on a relatively small number of selected individuals over a short period. Once these products are used by the general population—comprising a heterogeneous group that includes individuals with concurrent diseases—they may exhibit side effects. Therefore, pharmacovigilance focuses on identifying adverse drug reactions, monitoring the safety of drugs in use, and implementing appropriate actions to minimize associated risks. It also supports patients by informing them about safer medicines, thereby improving patient care.

Consequently, pharmacovigilance is a key health activity undertaken by governments and institutions aimed at enhancing patient safety and public health by mitigating the risks of adverse effects from medicines and vaccines. Pharmacovigilance encompasses various activities, including collecting and managing data on the safety of medicines, identifying adverse drug reactions, risk management to mitigate potential risks, regulatory actions, and communication with stakeholders to disseminate information and create public awareness. Key stakeholders involved in pharmacovigilance include patients, doctors, pharmacists, regulatory authorities, and pharmaceutical companies.

What is Driving the Pharmacovigilance Market?

• The Rising Cases of Adverse Drug Reactions

The increasing consumption of pharmaceutical products such as medicines and vaccines—driven by the rising prevalence of chronic diseases like cancer and diabetes—has led to a surge in side effects or harmful effects associated with drug use. According to the World Health Organization (WHO), cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020 (approximately one in six deaths). The National Cancer Institute estimates that 2,001,140 new cancer cases were diagnosed in the United States in 2024, with more than 611,720 people expected to die from cancer. Additionally, the number of individuals with diabetes has risen dramatically from 200 million in 1990 to 830 million in 2022. This increase in chronic diseases has heightened the demand for drugs and consequently led to more cases of adverse drug reactions.

Furthermore, the rise in self-medication and the use of over-the-counter drugs have increased risks associated with improper drug use, contributing to a higher incidence of adverse drug reactions that impact public safety. As a result, regulatory bodies are monitoring these adverse drug reaction cases more closely after drug approval to ensure patient safety. Governments and institutions are proactively addressing the growing incidence of adverse drug effects by establishing regulatory policies that pharmaceutical companies must comply with. For example, in the United States, the FDA requires drug manufacturers to conduct ongoing safety evaluations and periodically review their safety databases.

Simultaneously, regulatory authorities are implementing various initiatives to enhance drug safety and efficacy. For instance, the WHO’s program for international drug monitoring requires member countries to submit reports on adverse reactions associated with medicinal products to create a global database known as VigiBase. Therefore, the rising incidence of adverse drug reactions is prompting governments, institutions, and pharmaceutical companies to take action, driving the pharmacovigilance market growth.

• Advancements in Pharmacovigilance Technology

The need for effective pharmacovigilance has been amplified by advancements in technology such as artificial intelligence (AI), machine learning (ML), data management tools, analytical tools, predictive analysis, and risk management techniques. These technologies are transforming how the pharmacovigilance industry detects, analyzes, and manages adverse drug reactions. They facilitate efficient data collection and analysis using advanced tools like big data analytics while managing risk through predictive analysis.

For instance, machine learning can identify complex patterns or syndromes in safety data and perform predictive modeling tasks. It is also utilized to study interactions between drugs and human populations, aiding in investigating the benefits and risks of drug use under real-life conditions. Thus, integrating advanced tools is empowering the pharmacovigilance industry to develop innovative solutions that enhance accuracy in processes and ensure patient safety.

• Safety Innovations in the Pharmacovigilance Market

Several leading companies and regulatory bodies are driving innovative solutions within the pharmacovigilance market. Organizations such as WHO and the European Medicines Agency are implementing various regulatory frameworks alongside technological innovations to improve drug monitoring processes. Notable companies contributing to these advancements include Pfizer, Thermo Fisher Scientific Inc., Accenture, Oracle, IQVIA, Veeva Systems, Merck & Co., IBM Corporation, and Laboratory Corporation of America Holdings, among others.

Key Safety Innovations

• IQVIA: IQVIA provides pharmacovigilance and drug safety solutions through automation and advanced technologies. Its IQVIA Vigilance Platform operates in a SaaS environment that simplifies pharmacovigilance processes. It employs AI, ML, and Natural Language Processing (NLP) to identify adverse drug reactions by analyzing vast amounts of structured and unstructured data from clinical trials, hospitals, and health systems.
• Pfizer: Pfizer is at the forefront of using AI to monitor drugs safely. The company collects, analyzes, and reports extensive data using automated tools to streamline case processing and data management. Advanced signal detection tools are employed to analyze data from various sources while developing risk management plans and periodic safety update reports.
• Oracle: Oracle offers solutions that over 80% of pharmaceutical companies utilize for their pharmacovigilance needs. Their offerings include Oracle Argus Safety, Oracle Life Sciences Data Hub, Oracle Empirica Signal, and Oracle Safety Cloud, among others. Built-in Argus automation features intake processing, case prioritization, field validations, letters generation, and action items management, reducing manual work by over 50%. The integration of AI and ML enhances these capabilities significantly.

In summary, leaders in pharmacovigilance are leveraging advanced technologies such as AI and ML to transform operational processes by enabling earlier detection of adverse drug reactions while managing data effectively for insights. These innovations are propelling further advancements within the pharmacovigilance market aimed at ensuring patient safety. This revision enhances clarity while maintaining your original message. If you have any specific preferences or changes you’d like me to make, please let me know!

Find some of our related studies:

• Clinical Trial Market
• Mycoplasma Clinical Testing Market
• Global Burn Care Market